Clinical TrialCompleted

A Double-Blind Randomized Controlled Trial Using a Low Dose of Ketamine vs Active Placebo in Treating Severe Depression and Suicide

Parallel randomized double-blind trial of a single IV infusion of ketamine 0.5 mg/kg vs midazolam 0.045 mg/kg (active placebo) in adults 20–65 with treatment-resistant depression and prominent suicidal ideation. Target enrollment: 48. Primary outcome: rate of reduction in suicide symptoms post-infusion. Conducted at Taipei Veterans General Hospital, Taiwan. Funded by the Ministry of Science and Technology.

Target Enrollment
48 participants
Study Type
interventional
Design
Randomized, double Blind

Study Details

  • Status
    Completed
  • Type
    interventional
  • Design
    Randomizeddouble Blind
  • Target Enrollment48 participants
  • Timeline
    Start: 2018-08-15
    End: 2021-11-18

Related Publications

A pilot randomized controlled trial of ketamine in Borderline Personality Disorder

Published
Authors
Fineberg, S. K., Choi, E. Y., Shapiro-Thompson, R., Dhaliwal, K., Neustadter, E., Sakheim, M., Null, K., Trujillo-Diaz, D., Rondeau, J., Pittaro, G. F., Peters, J. R., Corlett, P. R., Krystal, J. H.

A Randomized Double-Blind Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation

Published
Authors
Su, T. P., Li, C. T., Lin, W. C., Wu, H. J., Tsai, S. J., Bai, Y. M., Mao, W. C., Tu, P. C., Chen, L. F., Li, W. C., Chen, M. H.

Your Library

A Double-Blind Randomized Controlled Trial Using... — Clinical Trial Details | Blossom